|
Telatinib
Description of:Telatinib
Telatinib (BAY 57-9352, CP 127374; KOS 953; NSC 330507; Tanespimycin) also inhibits VEGF-dependent proliferation of hu...
More>>
|
|
|
Erlotinib hydrochloride
Description of:Erlotinib hydrochloride
Erlotinib is an inhibitor of human Epidermal growth factor receptor (EGFR) tyrosine kinase (IC50 = 2 nM)...
More>>
|
|
|
Imatinib
Description of:Imatinib
Imatinib (originally STI571) is a drug used to treat certain cancers. It is marketed by Novartis as Gleevec (USA) or Gl...
More>>
|
|
|
R406
Description of:R406
R406 was selective as assessed using a large panel of Syk-independent cell-based assays representing both specific and gene...
More>>
|
|
|
Vandetanib
Theoretical analysis:Vandetanib
Molecular Formula: C22H24BrFN4O2
Formula Weight: 475.35
CAS No.: 443913-73-3
Ava...
More>>
|
|
|
Axitinib
Theoretical analysis:Axitinib
Molecular Formula: C22H18N4OS
Formula Weight: 386.47
CAS No.: 319460-85-0
Availabi...
More>>
|
|
|
Dasatinib
Theoretical analysis:Dasatinib
Molecular Formula: C22H28ClN7O3S
Formula Weight: 506.02082
CAS No.: 863127-77-9
A...
More>>
|
|
|
GSK1838705A
Description of:GSK1838705A
GSK1838705A prevents the in vitro proliferation of cell lines derived from solid and hematologic malignancies, inclu...
More>>
|
|
|
ASP 3026
Description of:ASP 3026
ASP-3026 is an ALK inhibitor in clinical trials
Theoretical analysis:ASP 3026
Molecular Formula C...
More>>
|
|
|
AST-6
Description of:AST-6
AST-6, a rationally designed novel anilino-quinazoline compound, inhibited enzymatic activities of wild type EGFR and ErbB...
More>>
|
|